Create New Account Purchaser Login
Search Tenders
Search
Advanced Search
You are not logged in.

Oral Fluid Screening Devices

Details

RFx ID : 23382306
Tender Name : Oral Fluid Screening Devices
Reference # :
Open Date : Q3 2020
Indicative RFx Release Date  : Q1 2021  [?]
Tender Type : Future Procurement Opportunity (FPO)
Project Status : Awaiting approval  [?]
Expected number of contracts offered : 1
Tender Coverage : Sole Agency  [?]
Categories :
  • 41000000 - Laboratory and Measuring and Observing and Testing Equipment
Regions:
  • New Zealand
Required Pre-qualifications : None
Contact : Contracts Administrator
Overview

"The New Zealand Governments new drug driving legislation when enacted will introduce a compulsory random roadside oral fluid testing scheme under which a Police officer can stop any driver of a motor vehicle and administer an oral fluid test without cause to suspect a driver has consumed drugs, consistent with the approach to drink driving enforcement.The proposed policy to enhance New Zealand’s drug-driving testing regime involves the introduction of an oral fluid (saliva) screening device.The oral fluid screening device will operate alongside and complement, the existing compulsory impairment test process. A Request for Information (RFI) is currently being drafted and is scheduled to be published by the end of October 2020. The passing of the Bill is currently aimed for March/April 2021.From the point the Bill passes, Police have 12 months to procure and implement an oral fluid screening device to all front line staff. This timeframe also needs to include any mobility technology or OnDuty changes that may be required as well as ensuring all staff are appropriately trained on the legislation and equipment procured.



This is a Future Procurement Opportunity (FPO) listing in line with MBIE's recent direction to list FPOs on here rather than in the usual APP format on their site. Any future RFx documentation will be posted on GETS linked to this FPO if and when appropriate. There is no additional information available at this time.